Wattana Sukeepaisarnjaroen

Khon Kaen University — Thailand

Medicine · Health Sciences

26h-index4.3kcitations127works39.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Liver Disease Diagnosis and Treatment(47), Hepatitis B Virus Studies(37), Hepatitis C virus research(34), Hepatocellular Carcinoma Treatment and Prognosis(31), Liver Disease and Transplantation(11)

Publications126 total

Urinary pesticide profiles and liver disease risk in Thailand: a machine-learning risk-prediction model
2025Open Access
Immunomics-guided biomarker discovery for human liver fluke infection and infection-associated cholangiocarcinoma
Nature Communications·2025Open Access
Immune-mediated adverse events and overall survival with tremelimumab plus durvalumab and durvalumab monotherapy in unresectable HCC: HIMALAYA phase III randomized clinical trial
Hepatology·2025· 8 citedOpen Access
LBP-035 Addition of triple biomarkers and/or GALAD score to ultrasound enhances the sensitivity of HCC surveillance: a multi-centre randomised controlled trial
Journal of Hepatology·2025
Five-year overall survival update from the HIMALAYA study of tremelimumab plus durvalumab in unresectable HCC
Journal of Hepatology·2025· 68 cited
Immunomics-guided biomarker discovery for human liver fluke infection and infection-associated cholangiocarcinoma
2025Open Access
Optical Diagnosis of Liver Cirrhosis and Hepatocellular Carcinoma using Machine Learning-Assisted Serum Raman Spectroscopy
Engineered Science·2025Open Access
Review of: "A Harmless Avian Vaccine Virus Could Be Developed into an Off-the-Shelf “Antibiotic” for Viruses"
2024Open Access
Outcomes in the Asian subgroup of the phase III randomised HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma
Journal of Hepatology·2024· 27 citedOpen Access
Hepatocellular Carcinoma in Asia: Physician and Patient Perspectives on Surveillance, Diagnosis, and Treatment
Journal of Gastrointestinal Cancer·2024· 4 citedOpen Access
The landscape of etiological patterns of hepatocellular carcinoma and intrahepatic cholangiocarcinoma in Thailand
International Journal of Cancer·2024· 13 citedOpen Access
Pooled prevalences of obstructive sleep apnea and heart failure: a systematic review and meta-analysis
Heart Failure Reviews·2024· 4 cited
A new biomarker panel for differential diagnosis of cholangiocarcinoma: Results from an exploratory analysis
The International Journal of Biological Markers·2024· 3 citedOpen Access
Cost-utility analysis of atezolizumab combined with bevacizumab for unresectable hepatocellular carcinoma in Thailand
PLoS ONE·2024· 7 citedOpen Access
Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma
Annals of Oncology·2024· 256 citedOpen Access
Cabozantinib plus atezolizumab versus sorafenib for advanced hepatocellular carcinoma (COSMIC-312): final results of a randomised phase 3 study
˜The œLancet. Gastroenterology & hepatology·2024· 66 citedOpen Access
Immunomics-Guided Biomarker Discovery for Opisthorchiasis and Opisthorchiasis-Associated Cholangiocarcinoma
SSRN Electronic Journal·2024Open Access
Pan-viral serology uncovers distinct virome patterns as risk predictors of hepatocellular carcinoma and intrahepatic cholangiocarcinoma
Cell Reports Medicine·2023· 13 citedOpen Access
An association between calcium channel blocker and breast cancer in patients with hypertension: A case-control study
Medicine in Drug Discovery·2023· 2 citedOpen Access
147P Four-year overall survival (OS) update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma (uHCC)
Annals of Oncology·2023· 4 citedOpen Access
page 1 of 7Next →

Frequent Co-authors

Stephen L. Chan(14), Pisit Tangkijvanich(11), Masatoshi Kudo(10), Robin Kate Kelley(10), Lorenza Rimassa(10), Yoon‐Koo Kang(9), В. В. Бредер(9), Tawesak Tanwandee(9), George Lau(8), Ann‐Lii Cheng(8), Edward Gane(8), Ghassan K. Abou‐Alfa(7), Vincent C. Tam(7), Thomas Yau(7), Alejandra Negro(7), Teerha Piratvisuth(7), Junji Furuse(6), Tu Van Dao(6), Alexandra Heurgué(6), Bruno Sangro(6)